CoChat

Parkin is recruited selectively to impaired mitochondria and promotes their autophagy

Open access
Narendra, Derek, Tanaka, Atsushi, Suen, Der-Fen, Youle, Richard J. · 2008 · The Journal of Cell Biology

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Loss-of-function mutations in Park2, the gene coding for the ubiquitin ligase Parkin, are a significant cause of early onset Parkinson's disease. Although the role of Parkin in neuron maintenance is unknown, recent work has linked Parkin to the regulation of mitochondria. Its loss is associated with swollen mitochondria and muscle degeneration in Drosophila melanogaster, as well as mitochondrial dysfunction and increased susceptibility to mitochondrial toxins in other species. Here, we show that Parkin is selectively recruited to dysfunctional mitochondria with low membrane potential in mammalian cells. After recruitment, Parkin mediates the engulfment of mitochondria by autophagosomes and the selective elimination of impaired mitochondria. These results show that Parkin promotes autophagy of damaged mitochondria and implicate a failure to eliminate dysfunctional mitochondria in the pathogenesis of Parkinson's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1083/jcb.200809125

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Parkin accumulates on impaired mitochondria. (a and b) HEK293 cells treated with DMSO control (a) or 10 μM CCCP (b) for 1 h immunostained for endogenous Parkin (green) and a mitochondrial marker, Tom20 (red). The bottom panels show enlarged views of the boxed areas. Arrows indicate mitochondria that colocalize with endogenous Parkin. (c and d) HEK293 cells (c) and rat cortical neurons (d) depolarized with CCCP for 1 and 5 h, respectively. Cells were immunoblotted for endogenous Parkin. PNS, HM, and PHM indicate postnuclear supernatant, mitochondrial-rich heavy membrane pellet, and post–heavy membrane supernatant, respectively. VDAC is a mitochondrial marker. (e) HeLa cells expressing YFP-Parkin (green) treated with DMSO, 10 μM CCCP, or 10 μM CCCP + 10 μM oligomycin for 1 h. Cells were stained for the mitochondrial marker cytochrome c (red). Line scans below the images indicate colocalization between Parkin (green) and mitochondria (red) and correlate to the lines drawn in the images. (f) YFP-Parkin colocalization with mitochondria scored for ≥300 cells per condition in at least two experiments. (g) YFP-Parkin accumulation in mitochondrial fraction assessed as in panel c. Numbers to the right of the gel blots indicate molecular weight standards in kD. (h) HeLa cells treated with 2 mM paraquat or paraquat + 10 mM N-acetyl-cysteine (NAC) for 24 h scored for colocalization, as in panel f. Error bars indicate standard deviation of at least three replicates. Bars, 10 μm.
Figure 1. Parkin accumulates on impaired mitochondria. (a and b) HEK293 cells treated with DMSO control (a) or 10 μM CCCP (b) for 1 h immunostained for endogenous Parkin (green) and a mitochondrial marker, Tom20 (red). The bottom panels show enlarged views of the boxed areas. Arrows indicate mitochondria that colocalize with endogenous Parkin. (c and d) HEK293 cells (c) and rat cortical neurons (d) depolarized with CCCP for 1 and 5 h, respectively. Cells were immunoblotted for endogenous Parkin. PNS, HM, and PHM indicate postnuclear supernatant, mitochondrial-rich heavy membrane pellet, and post–heavy membrane supernatant, respectively. VDAC is a mitochondrial marker. (e) HeLa cells expressing YFP-Parkin (green) treated with DMSO, 10 μM CCCP, or 10 μM CCCP + 10 μM oligomycin for 1 h. Cells were stained for the mitochondrial marker cytochrome c (red). Line scans below the images indicate colocalization between Parkin (green) and mitochondria (red) and correlate to the lines drawn in the images. (f) YFP-Parkin colocalization with mitochondria scored for ≥300 cells per condition in at least two experiments. (g) YFP-Parkin accumulation in mitochondrial fraction assessed as in panel c. Numbers to the right of the gel blots indicate molecular weight standards in kD. (h) HeLa cells treated with 2 mM paraquat or paraquat + 10 mM N-acetyl-cysteine (NAC) for 24 h scored for colocalization, as in panel f. Error bars indicate standard deviation of at least three replicates. Bars, 10 μm.CC BY-NC-SA · PubMed Central
Figure 2. FLIP analysis of Parkin diffusibility and selectivity of Parkin accumulation. (a–c) FLIP analysis with quantification after treatment with DMSO (a, top, and b) or CCCP (a, bottom, and c; n ≥ 3 in each treatment). Rectangles in panel a indicate the bleach ROI. Outlines demarcate the edges of cells expressing YFP-Parkin. (d) YFP localization in WT and Mfn1−/−,Mfn2−/− double knockout MEF cells expressing YFP-Parkin. (e) YFP-Parkin scored for colocalization as in Fig. 1 f. Error bars indicate standard deviation of at least three replicates. (f) Mfn1−/−,Mfn2−/− double knockout MEF cells transfected with YFP-Parkin (green) and pulsed with the potentiometric dye MitoTracker (blue in merge) 15 min before fixation. Cells were immunostained for cytochrome c (red). A line scan of fluorescence through two Parkin-positive mitochondria depicts colocalization between Parkin, MitoTracker, and cytochrome c. The right four panels show an enlarged view of the boxed area. Arrows indicate mitochondria (identified by anti–cytochrome c) that were depolarized (as assessed by their failure to take up the dye MitoTracker; arrowheads represent mitochondria (identified by anti–cytochrome c) that were electrochemically active (as assessed by their ability to take up the dye MitoTracker). YFP-Parkin colocalizes with depolarized mitochondria (arrows) but not with electrochemically active mitochondria. (g) The mitochondrial volume for each Mfn1−/−,Mfn2−/− MEF cell was segregated into Parkin-positive and Parkin-negative subsets. Mean MitoTracker fluorescence intensity was measured for each subset (n = 9). Bars: (a, d, and f, left) 5 μm; (f, right four panels) 1 μm.
Figure 2. FLIP analysis of Parkin diffusibility and selectivity of Parkin accumulation. (a–c) FLIP analysis with quantification after treatment with DMSO (a, top, and b) or CCCP (a, bottom, and c; n ≥ 3 in each treatment). Rectangles in panel a indicate the bleach ROI. Outlines demarcate the edges of cells expressing YFP-Parkin. (d) YFP localization in WT and Mfn1−/−,Mfn2−/− double knockout MEF cells expressing YFP-Parkin. (e) YFP-Parkin scored for colocalization as in Fig. 1 f. Error bars indicate standard deviation of at least three replicates. (f) Mfn1−/−,Mfn2−/− double knockout MEF cells transfected with YFP-Parkin (green) and pulsed with the potentiometric dye MitoTracker (blue in merge) 15 min before fixation. Cells were immunostained for cytochrome c (red). A line scan of fluorescence through two Parkin-positive mitochondria depicts colocalization between Parkin, MitoTracker, and cytochrome c. The right four panels show an enlarged view of the boxed area. Arrows indicate mitochondria (identified by anti–cytochrome c) that were depolarized (as assessed by their failure to take up the dye MitoTracker; arrowheads represent mitochondria (identified by anti–cytochrome c) that were electrochemically active (as assessed by their ability to take up the dye MitoTracker). YFP-Parkin colocalizes with depolarized mitochondria (arrows) but not with electrochemically active mitochondria. (g) The mitochondrial volume for each Mfn1−/−,Mfn2−/− MEF cell was segregated into Parkin-positive and Parkin-negative subsets. Mean MitoTracker fluorescence intensity was measured for each subset (n = 9). Bars: (a, d, and f, left) 5 μm; (f, right four panels) 1 μm.CC BY-NC-SA · PubMed Central
Figure 3. Mitochondrial fragmentation does not induce Parkin accumulation independently of mitochondrial membrane potential. (a–d) HeLa cells cotransfected with YFP-Parkin (green) and with empty vector (a), vMIA (b), or Drp1 K38A (c). Cells were treated with 10 μM CCCP (a, right, and c) or DMSO (a, left, and b) for 1 h. Mitochondria were immunostained for cytochrome c (red). The bottom two panels in each column show an enlarged view of the boxed regions. (d) YFP-Parkin colocalization with mitochondria were scored as in Fig. 1 f. Error bars indicate standard deviation of at least three replicates. Bars, 5 μm.
Figure 3. Mitochondrial fragmentation does not induce Parkin accumulation independently of mitochondrial membrane potential. (a–d) HeLa cells cotransfected with YFP-Parkin (green) and with empty vector (a), vMIA (b), or Drp1 K38A (c). Cells were treated with 10 μM CCCP (a, right, and c) or DMSO (a, left, and b) for 1 h. Mitochondria were immunostained for cytochrome c (red). The bottom two panels in each column show an enlarged view of the boxed regions. (d) YFP-Parkin colocalization with mitochondria were scored as in Fig. 1 f. Error bars indicate standard deviation of at least three replicates. Bars, 5 μm.CC BY-NC-SA · PubMed Central
Figure 4. Selective mitochondrial elimination by Parkin under depolarizing conditions. (a and b) HeLa cells expressing YFP-Parkin (green) incubated for 12 h (a) or 48 h (b, left) with 10 μM CCCP. Cells were immunostained for Tom20 (red). Parkin-expressing HeLa cells display less mitochondrial mass compared with surrounding cells at 12 h and complete loss of mitochondria by 48 h. (b) Similar loss of mitochondria observed with anti–cytochrome c (red, middle) and anti-TRAP1 (red, right) antibodies. (c) No loss of peroxisomes immunostained for PMP70 (red) in YFP-Parkin–transfected cells relative to surrounding untransfected cells. Outlines demarcate the edges of cells expressing YFP-Parkin. Bars, 10 μm. (d–f) Electron microscopy of untransfected HeLa cells (d) or HeLa cells expressing YFP-Parkin (e) and treated with 10 μM CCCP for 48 h. Many mitochondria and few lysosomes were observed in control cells, and no mitochondria and many lysosomes were observed in YFP-Parkin–transfected cells. Bars, 500 nm. (f) The number of mitochondria and late lysosomes/μm2 of cytoplasm in 22 randomly selected cells per condition. (g) The number of PMP70-stained peroxisomes per cell in YFP-Parkin–transfected and untransfected cells (n = 5). Error bars indicate standard deviation of at least three replicates. (h) Control HeLa cells or HeLa cells transfected with YFP-Parkin treated with 10 μM CCCP for 72 h (day 0) and cultured in glucose or galactose media for 1–4 d. Cells were fixed and stained for Tom20 and Hoechst33342 (nuclei). Cells with nonapoptotic nuclei in a representative area of the slide on days 0–4 were counted and represented in the graph as a percentage of nonapoptotic cells on day 0 (≥160 cells per condition on day 0 in at least two experiments).
Figure 4. Selective mitochondrial elimination by Parkin under depolarizing conditions. (a and b) HeLa cells expressing YFP-Parkin (green) incubated for 12 h (a) or 48 h (b, left) with 10 μM CCCP. Cells were immunostained for Tom20 (red). Parkin-expressing HeLa cells display less mitochondrial mass compared with surrounding cells at 12 h and complete loss of mitochondria by 48 h. (b) Similar loss of mitochondria observed with anti–cytochrome c (red, middle) and anti-TRAP1 (red, right) antibodies. (c) No loss of peroxisomes immunostained for PMP70 (red) in YFP-Parkin–transfected cells relative to surrounding untransfected cells. Outlines demarcate the edges of cells expressing YFP-Parkin. Bars, 10 μm. (d–f) Electron microscopy of untransfected HeLa cells (d) or HeLa cells expressing YFP-Parkin (e) and treated with 10 μM CCCP for 48 h. Many mitochondria and few lysosomes were observed in control cells, and no mitochondria and many lysosomes were observed in YFP-Parkin–transfected cells. Bars, 500 nm. (f) The number of mitochondria and late lysosomes/μm2 of cytoplasm in 22 randomly selected cells per condition. (g) The number of PMP70-stained peroxisomes per cell in YFP-Parkin–transfected and untransfected cells (n = 5). Error bars indicate standard deviation of at least three replicates. (h) Control HeLa cells or HeLa cells transfected with YFP-Parkin treated with 10 μM CCCP for 72 h (day 0) and cultured in glucose or galactose media for 1–4 d. Cells were fixed and stained for Tom20 and Hoechst33342 (nuclei). Cells with nonapoptotic nuclei in a representative area of the slide on days 0–4 were counted and represented in the graph as a percentage of nonapoptotic cells on day 0 (≥160 cells per condition on day 0 in at least two experiments).CC BY-NC-SA · PubMed Central
Figure 5. Mitophagy induced by Parkin. (a) HeLa cells stably expressing GFP-LC3 (green) transfected with mCherry-Parkin (not depicted) and treated with 10 μM CCCP for 1 h. Parkin-negative cells (left) display less overlap between autophagosomes and mitochondria (red) than Parkin-positive cells (right), as assessed by (b) counting the number of mitochondria encapsulated by LC3-positive autophagosomes in >30 cells per condition in at least three independent experiments. (c) HeLa cells stably expressing GFP-LC3 (green) and transiently transfected with mCherry-Parkin (white) were immunostained for cytochrome c (red) to reveal colocalization of LC3, Parkin, and mitochondria after 1 h exposure to CCCP. Arrows indicate mitochondria that colocalize with both mCherry-Parkin and GFP-LC3. Insets show an enlarged view of the boxed areas. (d) YFP-Parkin (green)-induced mitochondrial removal after 24 h of CCCP (10 μM) exposure observed in WT MEFs (left) failed to occur in ATG5−/− MEFs (right) quantified (e) in ≥150 cells in at least three experiments. Cells were stained for Tom20 (red). Outlines demarcate the edges of cells expressing YFP-Parkin. (f) 3-methyladenine (3MA) and bafilomycin blocked Parkin-induced mitophagy in HeLa cells quantified as in panel e. Error bars indicate standard deviation of at least three replicates. Bars: (c and d) 10 μm; (a and c, insets) 1 μm.
Figure 5. Mitophagy induced by Parkin. (a) HeLa cells stably expressing GFP-LC3 (green) transfected with mCherry-Parkin (not depicted) and treated with 10 μM CCCP for 1 h. Parkin-negative cells (left) display less overlap between autophagosomes and mitochondria (red) than Parkin-positive cells (right), as assessed by (b) counting the number of mitochondria encapsulated by LC3-positive autophagosomes in >30 cells per condition in at least three independent experiments. (c) HeLa cells stably expressing GFP-LC3 (green) and transiently transfected with mCherry-Parkin (white) were immunostained for cytochrome c (red) to reveal colocalization of LC3, Parkin, and mitochondria after 1 h exposure to CCCP. Arrows indicate mitochondria that colocalize with both mCherry-Parkin and GFP-LC3. Insets show an enlarged view of the boxed areas. (d) YFP-Parkin (green)-induced mitochondrial removal after 24 h of CCCP (10 μM) exposure observed in WT MEFs (left) failed to occur in ATG5−/− MEFs (right) quantified (e) in ≥150 cells in at least three experiments. Cells were stained for Tom20 (red). Outlines demarcate the edges of cells expressing YFP-Parkin. (f) 3-methyladenine (3MA) and bafilomycin blocked Parkin-induced mitophagy in HeLa cells quantified as in panel e. Error bars indicate standard deviation of at least three replicates. Bars: (c and d) 10 μm; (a and c, insets) 1 μm.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

10 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 4,026

Metadata

Authors
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J.
Affiliations
National Institutes of Health (US)
Venue
The Journal of Cell Biology
Published
2008-11-24
Volume
183
Issue
5
Pages
795-803
ISSN
  • 0021-9525 (ISSN-L)
  • 1540-8140
OpenAlex
W2155015733
Cited by
4,026
References
32
Citations by year
2026: 205 · 2025: 220 · 2024: 214 · 2023: 211 · 2022: 262 · 2021: 267 · 2020: 264 · 2019: 239 · 2018: 249 · 2017: 243 · 2016: 246 · 2015: 222 · 2014: 252 · 2013: 249 · 2012: 231
FWCI
110.61
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • Japan Society for the Promotion of Science
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
Parkin, PARK2, Parkinson's disease, mitophagy, selective autophagy, mitochondrial dysfunction, mitochondrial membrane potential, ubiquitin ligase, autophagosomes, mitochondrial clearance
MeSH terms
Animals, Autophagy, Fibroblasts, HeLa Cells, Humans, Microtubule-Associated Proteins, Mitochondria, Neurons, Parkinson Disease, Recombinant Fusion Proteins, Time Factors, Transfection, Uncoupling Agents, Mice, Knockout, GTP Phosphohydrolases, Protein Transport, Ubiquitin-Protein Ligases, Mice, Rats, Membrane Potential, Mitochondrial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.